TY - JOUR AU - Ballestrero, A. AU - Garuti, A. AU - Cirmena, G. AU - Rocco, I. AU - Palermo, C. AU - Nencioni, A. PY - 2012 DA - 2012// TI - Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond JO - Curr Cancer Drug Targets VL - 12 UR - https://doi.org/10.2174/156800912800190956 DO - 10.2174/156800912800190956 ID - Ballestrero2012 ER - TY - JOUR AU - Karapetis, C. S. AU - Khambata-Ford, S. AU - Jonker, D. J. AU - O’Callaghan, C. J. AU - Tu, D. AU - Tebbutt, N. C. PY - 2008 DA - 2008// TI - K-ras mutations and benefit from cetuximab in advanced colorectal cancer JO - N Engl J Med VL - 359 UR - https://doi.org/10.1056/NEJMoa0804385 DO - 10.1056/NEJMoa0804385 ID - Karapetis2008 ER - TY - JOUR AU - Zoppoli, G. AU - Moran, E. AU - Soncini, D. AU - Cea, M. AU - Garuti, A. AU - Rocco, I. PY - 2010 DA - 2010// TI - Ras-induced resistance to lapatinib is overcome by MEK inhibition JO - Curr Cancer Drug Targets VL - 10 UR - https://doi.org/10.2174/156800910791054211 DO - 10.2174/156800910791054211 ID - Zoppoli2010 ER - TY - JOUR AU - Cutsem, E. AU - Kohne, C. H. AU - Hitre, E. AU - Zaluski, J. AU - Chang Chien, C. R. AU - Makhson, A. PY - 2009 DA - 2009// TI - Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer JO - N Engl J Med VL - 360 UR - https://doi.org/10.1056/NEJMoa0805019 DO - 10.1056/NEJMoa0805019 ID - Cutsem2009 ER - TY - JOUR AU - Sorich, M. J. AU - Wiese, M. D. AU - Rowland, A. AU - Kichenadasse, G. AU - McKinnon, R. A. AU - Karapetis, C. S. PY - 2015 DA - 2015// TI - Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials JO - Ann Oncol VL - 26 UR - https://doi.org/10.1093/annonc/mdu378 DO - 10.1093/annonc/mdu378 ID - Sorich2015 ER - TY - JOUR AU - Pietrantonio, F. AU - Petrelli, F. AU - Coinu, A. AU - Bartolomeo, M. AU - Borgonovo, K. AU - Maggi, C. PY - 2015 DA - 2015// TI - Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: a meta-analysis JO - Eur J Cancer VL - 51 UR - https://doi.org/10.1016/j.ejca.2015.01.054 DO - 10.1016/j.ejca.2015.01.054 ID - Pietrantonio2015 ER - TY - JOUR AU - Sartore-Bianchi, A. AU - Martini, M. AU - Molinari, F. AU - Veronese, S. AU - Nichelatti, M. AU - Artale, S. PY - 2009 DA - 2009// TI - PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-08-2466 DO - 10.1158/0008-5472.CAN-08-2466 ID - Sartore-Bianchi2009 ER - TY - JOUR AU - Ciardiello, F. AU - Normanno, N. AU - Maiello, E. AU - Martinelli, E. AU - Troiani, T. AU - Pisconti, S. PY - 2014 DA - 2014// TI - Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next-generation sequencing: findings from the CAPRI-GOIM trial JO - Ann Oncol VL - 25 UR - https://doi.org/10.1093/annonc/mdu230 DO - 10.1093/annonc/mdu230 ID - Ciardiello2014 ER - TY - JOUR AU - Kumar, P. AU - Henikoff, S. AU - Ng, P. C. PY - 2009 DA - 2009// TI - Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm JO - Nat Protoc VL - 4 UR - https://doi.org/10.1038/nprot.2009.86 DO - 10.1038/nprot.2009.86 ID - Kumar2009 ER - TY - JOUR AU - Adzhubei, I. AU - Jordan, D. M. AU - Sunyaev, S. R. PY - 2013 DA - 2013// TI - Predicting functional effect of human missense mutations using PolyPhen-2 JO - Curr Protocols Hum Genet. VL - Chapter 7 ID - Adzhubei2013 ER - TY - JOUR AU - Reva, B. AU - Antipin, Y. AU - Sander, C. PY - 2011 DA - 2011// TI - Predicting the functional impact of protein mutations: application to cancer genomics JO - Nucleic Acids Res VL - 39 UR - https://doi.org/10.1093/nar/gkr407 DO - 10.1093/nar/gkr407 ID - Reva2011 ER - TY - JOUR AU - Friedman, J. AU - Hastie, T. AU - Tibshirani, R. PY - 2010 DA - 2010// TI - Regularization paths for generalized linear modelsvia coordinate descent JO - J Stat Softw VL - 33 UR - https://doi.org/10.18637/jss.v033.i01 DO - 10.18637/jss.v033.i01 ID - Friedman2010 ER - TY - JOUR AU - Schroder, M. S. AU - Culhane, A. C. AU - Quackenbush, J. AU - Haibe-Kains, B. PY - 2011 DA - 2011// TI - survcomp: an R/Bioconductor package for performance assessment and comparison of survival models JO - Bioinformatics VL - 27 UR - https://doi.org/10.1093/bioinformatics/btr511 DO - 10.1093/bioinformatics/btr511 ID - Schroder2011 ER - TY - BOOK AU - Venables, W. N. AU - Ripley, B. D. PY - 2002 DA - 2002// TI - Modern applied statistics with S PB - Springer CY - New York UR - https://doi.org/10.1007/978-0-387-21706-2 DO - 10.1007/978-0-387-21706-2 ID - Venables2002 ER - TY - JOUR AU - Gao, J. AU - Aksoy, B. A. AU - Dogrusoz, U. AU - Dresdner, G. AU - Gross, B. AU - Sumer, S. O. PY - 2013 DA - 2013// TI - Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal JO - Sci Signal. VL - 6 UR - https://doi.org/10.1126/scisignal.2004088 DO - 10.1126/scisignal.2004088 ID - Gao2013 ER - TY - JOUR AU - Cerami, E. AU - Gao, J. AU - Dogrusoz, U. AU - Gross, B. E. AU - Sumer, S. O. AU - Aksoy, B. A. PY - 2012 DA - 2012// TI - The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data JO - Cancer Discov VL - 2 UR - https://doi.org/10.1158/2159-8290.CD-12-0095 DO - 10.1158/2159-8290.CD-12-0095 ID - Cerami2012 ER - TY - STD TI - R Core Team. R: A language and environment for statistical computing.. R Foundation for Statistical Computing, Vienna, Austria; 2014. ID - ref17 ER - TY - JOUR AU - Dono, M. AU - Massucco, C. AU - Chiara, S. AU - Sonaglio, C. AU - Mora, M. AU - Truini, A. PY - 2013 DA - 2013// TI - Low percentage of KRAS mutations revealed by locked nucleic acid polymerase chain reaction: implications for treatment of metastatic colorectal cancer JO - Mol Med VL - 18 UR - https://doi.org/10.2119/molmed.2012.00175 DO - 10.2119/molmed.2012.00175 ID - Dono2013 ER - TY - JOUR AU - Douillard, J. Y. AU - Oliner, K. S. AU - Siena, S. AU - Tabernero, J. AU - Burkes, R. AU - Barugel, M. PY - 2013 DA - 2013// TI - Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1305275 DO - 10.1056/NEJMoa1305275 ID - Douillard2013 ER - TY - JOUR AU - Rowland, A. AU - Dias, M. M. AU - Wiese, M. D. AU - Kichenadasse, G. AU - McKinnon, R. A. AU - Karapetis, C. S. PY - 2015 DA - 2015// TI - Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal antibody therapy for RAS wild-type metastatic colorectal cancer JO - Br J Cancer VL - 112 UR - https://doi.org/10.1038/bjc.2015.173 DO - 10.1038/bjc.2015.173 ID - Rowland2015 ER - TY - JOUR AU - Cutsem, E. AU - Cervantes, A. AU - Adam, R. AU - Sobrero, A. AU - Krieken, J. H. AU - Aderka, D. PY - 2016 DA - 2016// TI - ESMO consensus guidelines for the management of patients with metastatic colorectal cancer JO - Ann Oncol VL - 27 UR - https://doi.org/10.1093/annonc/mdw235 DO - 10.1093/annonc/mdw235 ID - Cutsem2016 ER - TY - JOUR AU - Kopetz, S. AU - McDonough, S. L. AU - Morris, V. K. AU - Lenz, H. J. AU - Magliocco, A. M. AU - Atreya, C. E. PY - 2017 DA - 2017// TI - Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG 1406) JO - J Clin Oncol. VL - 35 UR - https://doi.org/10.1200/JCO.2017.35.4_suppl.520 DO - 10.1200/JCO.2017.35.4_suppl.520 ID - Kopetz2017 ER - TY - JOUR AU - Cremolini, C. AU - Loupakis, F. AU - Antoniotti, C. AU - Lupi, C. AU - Sensi, E. AU - Lonardi, S. PY - 2015 DA - 2015// TI - FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study JO - Lancet Oncol VL - 16 UR - https://doi.org/10.1016/S1470-2045(15)00122-9 DO - 10.1016/S1470-2045(15)00122-9 ID - Cremolini2015 ER - TY - JOUR AU - Jones, J. C. AU - Renfro, L. A. AU - Al-Shamsi, H. O. AU - Schrock, A. B. AU - Rankin, A. AU - Zhang, B. Y. PY - 2017 DA - 2017// TI - (Non-V600) BRAF mutations define a clinically distinct molecular subtype of metastatic colorectal cancer JO - J Clin Oncol VL - 35 UR - https://doi.org/10.1200/JCO.2016.71.4394 DO - 10.1200/JCO.2016.71.4394 ID - Jones2017 ER - TY - JOUR AU - Roock, W. AU - Claes, B. AU - Bernasconi, D. AU - Schutter, J. AU - Biesmans, B. AU - Fountzilas, G. PY - 2010 DA - 2010// TI - Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis JO - Lancet Oncol VL - 11 UR - https://doi.org/10.1016/S1470-2045(10)70130-3 DO - 10.1016/S1470-2045(10)70130-3 ID - Roock2010 ER - TY - JOUR AU - Holch, J. W. AU - Ricard, I. AU - Stintzing, S. AU - Modest, D. P. AU - Heinemann, V. PY - 2017 DA - 2017// TI - The relevance of primary tumour location in patients with metastatic colorectal cancer: a meta-analysis of first-line clinical trials JO - Eur J Cancer VL - 70 UR - https://doi.org/10.1016/j.ejca.2016.10.007 DO - 10.1016/j.ejca.2016.10.007 ID - Holch2017 ER - TY - JOUR AU - Jensen, C. E. AU - Loaiza-Bonilla, A. AU - Villanueva, J. Y. AU - Morrissette, J. J. PY - 2017 DA - 2017// TI - Differences in mutation rates between right- and left-sided colorectal adenocarcinoma JO - J Clin Oncol. VL - 35 UR - https://doi.org/10.1200/JCO.2017.35.4_suppl.622 DO - 10.1200/JCO.2017.35.4_suppl.622 ID - Jensen2017 ER - TY - JOUR AU - Lochhead, P. AU - Kuchiba, A. AU - Imamura, Y. AU - Liao, X. AU - Yamauchi, M. AU - Nishihara, R. PY - 2013 DA - 2013// TI - Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication JO - J Natl Cancer Inst VL - 105 UR - https://doi.org/10.1093/jnci/djt173 DO - 10.1093/jnci/djt173 ID - Lochhead2013 ER - TY - JOUR AU - Gonsalves, W. I. AU - Mahoney, M. R. AU - Sargent, D. J. AU - Nelson, G. D. AU - Alberts, S. R. AU - Sinicrope, F. A. PY - 2014 DA - 2014// TI - Patient and tumor characteristics and BRAF and KRAS mutations in colon cancer, NCCTG/Alliance N0147 JO - J Natl Cancer Inst. VL - 106 UR - https://doi.org/10.1093/jnci/dju106 DO - 10.1093/jnci/dju106 ID - Gonsalves2014 ER - TY - JOUR AU - Roth, A. D. AU - Tejpar, S. AU - Delorenzi, M. AU - Yan, P. AU - Fiocca, R. AU - Klingbiel, D. PY - 2010 DA - 2010// TI - Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.23.3452 DO - 10.1200/JCO.2009.23.3452 ID - Roth2010 ER - TY - JOUR AU - Macedo, M. P. AU - Andrade Lde, B. AU - Coudry, R. AU - Crespo, R. AU - Gomes, M. AU - Lisboa, B. C. PY - 2011 DA - 2011// TI - Multiple mutations in the Kras gene in colorectal cancer: review of the literature with two case reports JO - Int J Colorectal Dis VL - 26 UR - https://doi.org/10.1007/s00384-011-1238-0 DO - 10.1007/s00384-011-1238-0 ID - Macedo2011 ER - TY - JOUR AU - Jesinghaus, M. AU - Pfarr, N. AU - Endris, V. AU - Kloor, M. AU - Volckmar, A. L. AU - Brandt, R. PY - 2016 DA - 2016// TI - Genotyping of colorectal cancer for cancer precision medicine: results from the IPH Center for Molecular Pathology JO - Genes Chromosom Cancer VL - 55 UR - https://doi.org/10.1002/gcc.22352 DO - 10.1002/gcc.22352 ID - Jesinghaus2016 ER - TY - JOUR AU - Jesinghaus, M. AU - Pfarr, N. AU - Kloor, M. AU - Endris, V. AU - Tavernar, L. AU - Muckenhuber, A. PY - 2016 DA - 2016// TI - Genetic heterogeneity in synchronous colorectal cancers impacts genotyping approaches and therapeutic strategies JO - Genes Chromosom Cancer VL - 55 UR - https://doi.org/10.1002/gcc.22330 DO - 10.1002/gcc.22330 ID - Jesinghaus2016 ER - TY - JOUR AU - Schmitt, M. W. AU - Loeb, L. A. AU - Salk, J. J. PY - 2016 DA - 2016// TI - The influence of subclonal resistance mutations on targeted cancer therapy JO - Nat Rev Clin Oncol VL - 13 UR - https://doi.org/10.1038/nrclinonc.2015.175 DO - 10.1038/nrclinonc.2015.175 ID - Schmitt2016 ER - TY - JOUR AU - Summers, M. AU - Smith, C. G. AU - Maughan, T. S. AU - Kaplan, R. AU - Escott-Price, V. AU - Cheadle, J. P. PY - 2016 DA - 2016// TI - BRAF and NRAS locus specific variants have different outcomes on survival to colorectal cancer JO - Clin Cancer Res. VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-16-1541 DO - 10.1158/1078-0432.CCR-16-1541 ID - Summers2016 ER - TY - JOUR AU - Morkel, M. AU - Riemer, P. AU - Blaker, H. AU - Sers, C. PY - 2015 DA - 2015// TI - Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance JO - Oncotarget. VL - 6 UR - https://doi.org/10.18632/oncotarget.4750 DO - 10.18632/oncotarget.4750 ID - Morkel2015 ER - TY - JOUR AU - Jiang, L. AU - Huang, J. AU - Morehouse, C. AU - Zhu, W. AU - Korolevich, S. AU - Sui, D. PY - 2013 DA - 2013// TI - Low frequency KRAS mutations in colorectal cancer patients and the presence of multiple mutations in oncogenic drivers in non-small cell lung cancer patients JO - Cancer Genet VL - 206 UR - https://doi.org/10.1016/j.cancergen.2013.09.004 DO - 10.1016/j.cancergen.2013.09.004 ID - Jiang2013 ER - TY - JOUR AU - Eklof, V. AU - Wikberg, M. L. AU - Edin, S. AU - Dahlin, A. M. AU - Jonsson, B. A. AU - Oberg, A. PY - 2013 DA - 2013// TI - The prognostic role of KRAS, BRAF, PIK3CA and PTEN in colorectal cancer JO - Br J Cancer VL - 108 UR - https://doi.org/10.1038/bjc.2013.212 DO - 10.1038/bjc.2013.212 ID - Eklof2013 ER - TY - JOUR AU - Mei, Z. B. AU - Duan, C. Y. AU - Li, C. B. AU - Cui, L. AU - Ogino, S. PY - 2016 DA - 2016// TI - Prognostic role of tumor PIK3CA mutation in colorectal cancer: a systematic review and meta-analysis JO - Ann Oncol VL - 27 UR - https://doi.org/10.1093/annonc/mdw264 DO - 10.1093/annonc/mdw264 ID - Mei2016 ER - TY - JOUR AU - Arnold, D. AU - Lueza, B. AU - Douillard, J. Y. AU - Peeters, M. AU - Lenz, H. J. AU - Venook, A. PY - 2017 DA - 2017// TI - Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials JO - Ann Oncol VL - 28 UR - https://doi.org/10.1093/annonc/mdx175 DO - 10.1093/annonc/mdx175 ID - Arnold2017 ER - TY - JOUR AU - Galon, J. AU - Costes, A. AU - Sanchez-Cabo, F. AU - Kirilovsky, A. AU - Mlecnik, B. AU - Lagorce-Pages, C. PY - 2006 DA - 2006// TI - Type, density, and location of immune cells within human colorectal tumors predict clinical outcome JO - Science VL - 313 UR - https://doi.org/10.1126/science.1129139 DO - 10.1126/science.1129139 ID - Galon2006 ER - TY - JOUR AU - Gandhi, L. AU - Rodriguez-Abreu, D. AU - Gadgeel, S. AU - Esteban, E. AU - Felip, E. AU - Angelis, F. PY - 2018 DA - 2018// TI - Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer JO - N Engl J Med VL - 378 UR - https://doi.org/10.1056/NEJMoa1801005 DO - 10.1056/NEJMoa1801005 ID - Gandhi2018 ER - TY - JOUR AU - Eggermont, A. M. M. AU - Blank, C. U. AU - Mandala, M. AU - Long, G. V. AU - Atkinson, V. AU - Dalle, S. PY - 2018 DA - 2018// TI - Adjuvant pembrolizumab versus placebo in resected stage III Melanoma JO - N Engl J Med VL - 378 UR - https://doi.org/10.1056/NEJMoa1802357 DO - 10.1056/NEJMoa1802357 ID - Eggermont2018 ER - TY - JOUR AU - Diaz, L. A. AU - Marabelle, A. AU - Delord, J. -. P. AU - Shapira-Frommer, R. AU - Geva, R. AU - Peled, N. PY - 2017 DA - 2017// TI - Pembrolizumab therapy for microsatellite instability high (MSI-H) colorectal cancer (CRC) and non-CRC JO - J Clin Oncol. VL - 35 UR - https://doi.org/10.1200/JCO.2017.35.15_suppl.3071 DO - 10.1200/JCO.2017.35.15_suppl.3071 ID - Diaz2017 ER - TY - JOUR AU - Lal, N. AU - White, B. S. AU - Goussous, G. AU - Pickles, O. AU - Mason, M. J. AU - Beggs, A. D. PY - 2018 DA - 2018// TI - KRAS mutation and consensus molecular subtypes 2 and 3 are independently associated with reduced immune infiltration and reactivity in colorectal cancer JO - Clin Cancer Res VL - 24 UR - https://doi.org/10.1158/1078-0432.CCR-17-1090 DO - 10.1158/1078-0432.CCR-17-1090 ID - Lal2018 ER - TY - JOUR AU - Thorsson, V. AU - Gibbs, D. L. AU - Brown, S. D. AU - Wolf, D. AU - Bortone, D. S. AU - Ou Yang, T. H. PY - 2018 DA - 2018// TI - The immune landscape of Cancer JO - Immunity. VL - 48 UR - https://doi.org/10.1016/j.immuni.2018.03.023 DO - 10.1016/j.immuni.2018.03.023 ID - Thorsson2018 ER -